Firefly Neuroscience Inc (AIFF) - Biznesning o‘zini qoplash muddati
Firefly Neuroscience, Inc (AIFF) virtual EEG tahlili infratuzilmasiga tayanadi, bu esa jismoniy xarajatlarni bartaraf etadi va ma'lumotlar markazi operatsiyalarining barqarorligini ta'minlaydi. Kompaniya psixiatrlar uchun depressiya va Altsgeymer kasalligini raqamli aniqlash imkonini beruvchi bulutli servisni taqdim etish orqali daromad keltiradi. Ushbu narxlar grafigi diagnostikaga AI muvofiqligining integratsiyasi natijasida brendning a’lo darajadagi narx belgilash imkoniyati tufayli aktivning -1.90 miqdoridagi yuqori bozor bahosini tasdiqlaydi.
Firefly Neuroscience, Inc kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Jamlagan qarzning xususiy kapitalga nisbati Firefly Neuroscience, Inc|AIFF - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Firefly Neuro|AIFF - Kompaniyaning umumiy qarzi|Balans qiymatiga qarzlar Firefly Neuroscience, Inc.|AIFF - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Firefly Neuroscience|Shoshilinch likvidlik koeffitsiyenti fireflyneuro.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
AIFF - Sof foyda|Kutilayotgan sof foyda Firefly Neuroscience, Inc|AIFF - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Firefly Neuroscience, Inc.|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Firefly Neuroscience, Inc.|AIFF - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Firefly Neuroscience|AIFF - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi fireflyneuro.com|AIFF - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Firefly Neuroscience, Inc
Kompaniyaning umumiy tahlili:AIFF (fireflyneuro.com)
Ushbu ko'rsatkich Firefly Neuroscience, Inc (AIFF) bozor qiymati va uning haqiqiy daromadlari orasidagi nisbatni aks ettirib, aktivning shakllangan pul oqimlari nisbatan haddan tashqari qimmat baholanganligini aniqlash imkonini beradi. Kompaniyaning o'rtacha P/E ko'rsatkichini tahlil qilish orqali investor klinikalarda BNA platformasining kengayishiga nisbatan bozor kutganlarini baholaydi, bunda rahbariyatning AI miya tahlili sohasidagi yuqori kompetentsiyasi kelajakdagi o'sish uchun joriy premiumni oqlashi mumkin.
Raqobatdosh kompaniyalar
biogen.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori NBIX|Biznesning o‘zini qoplash muddati Regencell Bioscience Ltd|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|Kompaniya qiymatining sof foydaga nisbati ACAD|Xenon Pharmaceuticals - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati vikingtherapeutics.com|SUPN: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati CPRX (Catalyst Pharma)|Narxning foydaga nisbati Denali Therapeutics Inc|Narxning foydaga nisbati HRMY|Narx-foyda koeffitsiyenti BHVN (Biohaven Ltd.)|AMLX - Kapitalizatsiyaning foydaga nisbati|Trevi Therapeutics, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRAX|AVXL - Narxning foydaga nisbati|CBLL (CeriBell EEG) - Narx-foyda multiplikatori|PRTA: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Alector (ALEC)|Narx-foyda koeffitsiyenti ANNX|P/E multiplikatori Omeros Corp.|Narxning foydaga nisbati Neurogene Corp (NGNE)|ACIU (AC Immune Inc) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Voyager Therapeutics VYGR|neumoratx.com (NMRA) - Kapitalizatsiyaning foydaga nisbati|SCLX - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Tevogen Bio Holdings Inc. TVGN|ACOG: P/E multiplikatori|Narx-foyda koeffitsiyenti Cognition Therapeutics Inc.|IKT (Inhibikase Therapeutics) - P/E multiplikatori|cassavasciences.com (SAVA) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ASRT|COYA - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Vistagen VTGN|OVID: Narx-foyda multiplikatori|Acumen Pharmaceuticals - P/E multiplikatori|cervomed.com (CRVO) - Narx-foyda koeffitsiyenti|ATHE: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Clene (CLNN)|Narx-foyda koeffitsiyenti PEPG|JUNS: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori RLMD|Biznesning o‘zini qoplash muddati annovisbio.com|Narxning foydaga nisbati Grace Therapeutics GRCE|KLTO: Narx-foyda multiplikatori|NeuroSense Therapeutics, Ltd. - P/E multiplikatori|Reviva Pharmaceuticals, Inc. (RVPH) - Narx-foyda koeffitsiyenti|MTVA: P/E multiplikatori|neuraxis.com (NRXS) - P/E multiplikatori|HSDT (Helius Medical Technologies, Inc.) - P/E multiplikatori|Passage Bio Corp (PASG) - Biznesning o‘zini qoplash muddati|P/E multiplikatori NEUP|NERV: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ATHA (Athira Pharma, Inc.)|ADXN (addextherapeutics.com) - Kapitalizatsiyaning sof foydaga nisbati|ALZN - Narxning foydaga nisbati|CYCN (Cyclerion Therapeutics) - Narx-foyda multiplikatori|PTIX: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Pasithea Therapeutics Corp. (KTTA)|Narx-foyda koeffitsiyenti CRGT|P/E multiplikatori avenuetx.com|Narxning foydaga nisbati BrainStorm Cell Therapeutics (BCLI)|CARA (Cara Therapeutics Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|Eliem Therapeutics, Inc. (ELYM) - Kapitalizatsiyaning foydaga nisbati|Intra-Cellular - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati LBPH|MRNS: P/E multiplikatori|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|TRVN - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori VIGL (Vigil Neuroscience, Inc.)|WENA (anewmeds.com) - Kapitalizatsiyaning sof foydaga nisbati|CERE - Narxning foydaga nisbati
